NCT02107651已完成不适用
Serious Adverse Events in Patients Treated With New Oral Anticoagulants Are Underreported
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Proportion of patients admitted with adverse event reported to authorities
研究概览
简要总结
Serious adverse events in patients treated with new oral anticoagulants are underreported.
详细描述
The study investigates if serious adverse events in patients treated with NOAC are reported to the Health and Medicines Authority.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients admitted for GI bleeding while in treatment with NOAC
排除标准
- 未提供
结局指标
主要结局
Proportion of patients admitted with adverse event reported to authorities
时间窗: Within one year of admission
次要结局
未报告次要终点
研究者
Thue Bisgaard
Professor
Hvidovre University Hospital
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency DepartmentHemorrhageThrombosisAnticoagulant TherapyTraumatic HemorrhageNCT06692504Centre Hospitalier Universitaire de Besancon2,080
招募中
不适用
Pharmacists' Intervention in Patients Using Novel Oral Anticoagulants：A Study on Behavioral PatternsAnticoagulantsIntentionBehavioral SymptomsNCT03670446Cui Yimin400
招募中
不适用
Multi-effects of novel oral anticoagurants in nonvalvular atrial fibrillation studyJPRN-UMIN000010494Tokushima University hospital40
已完成
不适用
Bleeding events of direct oral anti-coagulant for treatment of venous thromboembolism in advanced cancer patients.Venous thromboembolismJPRN-UMIN000020275Shizuoka Cancer Center147
招募中
不适用
Effects of treatment with oral anticoagulant associated with antibiotic therapy in Covid-19Covid-19B04.820.578.500.540.150RBR-7nzwkpgniversidade do Sul de Santa Catarina